DICKINSON CRAIG DUANE,DRIVER DAVID ALBERT,DARLING RYAN JAMES,GONCIARZ MALGORZATA DONATA,MICANOVIC RADMILA
申请号:
IN782CHN2014
公开号:
IN782CHN2014A
申请日:
2014.01.30
申请国别(地区):
IN
年份:
2015
代理人:
摘要:
This present invention relates to pharmacologically potent and/or stable variants of human fibroblast growth factor 21 (FGF21) pharmaceutical compositions comprising FGF21 variants and methods for treating type 2 diabetes obesity dyslipidemia or metabolic syndrome or any combination thereof using such variants.